Francesco Montorsi, Marco Moschini, Andrea Necchi, Federico Deho, Giorgio Gandaglia, Alberto Briganti,
J Urol (The Journal of urology)
[2021, :101097JU0000000000002237]
Cited: 0 times
David D'Andrea, Peter C Black, Homayoun Zargar, Colin P Dinney, Francesco Soria, Michael S Cookson, Jeffrey S Montgomery, Wassim Kassouf, Marc A Dall'Era, Srikala S Sridhar, John S McGrath, Jonathan L Wright, Andrew C Thorpe, Jeff M Holzbeierlein, Diego M Carrión, Ettore Di Trapani, Trinity J Bivalacqua, Scott North, Daniel A Barocas, Yair Lotan, Petros Grivas, Andrew J Stephenson, Bas W van Rhijn, Siamak Daneshmand, Philippe E Spiess, Shahrokh F Shariat, Kamran Zargar-Shoshtar, Laura S Mertens, Adrian S Fairey, Maria C Mir, Laura-Maria Krabbe, Niels-Erik Jacobsen, Nikhil Vasdev, Evan Y Yu, Evanguelos Xylinas, Benjamin Pradere, Renate Pichler, Nicholas J Campain, Jo-An Seah, Cesar E Ercole, Simon Horenblas, Jonathan Aning, Todd M Morgan, Jay B Shah, Marco Moschini,
<h4>Purpose</h4>To investigate the pathologic response rates and survival associated with 3 versus 4 cycles of cisplatin-based NAC in patients with cT2-4N0M0 MIBC.<h4>Material and methods</h4>In this cohort study we analyzed clinical data of 828 patients treated with NAC and RC between 2000 and 2020<b>.</b> A total of 384 and 444 patients ... Read more >>
J Urol (The Journal of urology)
[2021, :101097JU0000000000002190]
Cited: 0 times
Chiara Lonati, Philipp Baumeister, Luca Afferi, Andrea Mari, Andrea Minervini, Wojciech Krajewski, Sosan Azizi, Kees Hendricksen, Alberto Martini, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Renzo Colombo, Alessandro Tafuri, Alessandro Antonelli, Maria Angela Cerruto, Morgan Rouprêt, Alexandra Masson-Lecomte, Ekaterina Laukhtina, David D'Andrea, Shahrokh F Shariat, Francesco Soria, Giancarlo Marra, Paolo Gontero, Roberto Contieri, Rodolfo Hurle, Anne Sophie Valiquette, M Carmen Mir, Stefania Zamboni, Claudio Simeone, Tobias Klatte, Jeremy Yuen-Chun Teoh, Soichiro Yoshida, Yasuhisa Fujii, Roberto Carando, Gerald B Schulz, Livio Mordasini, Agostino Mattei, Marco Moschini, ,
<h4>Background</h4>Literature lacks clear evidence regarding the optimal treatment for non-muscle-invasive micropapillary bladder cancer (MPBC) due to its rarity and the presence of only small sample size and single-centre studies.<h4>Objective</h4>To assess cancer-specific mortality (CSM) and overall mortality (OM) between immediate radical cystectomy (RC) and conservative management among T1 high-grade (HG) MPBC.<h4>Design, ... Read more >>
Eur Urol Focus (European urology focus)
[2021, :]
Cited: 0 times
Keiichiro Mori, Victor M Schuettfort, Satoshi Katayama, Ekaterina Laukhtina, Benjamin Pradere, Fahad Quhal, Reza Sari Motlagh, Hadi Mostafaei, Nico C Grossmann, Pawel Rajwa, Frederik König, Abdulmajeed Aydh, Francesco Soria, Marco Moschini, Pierre I Karakiewicz, Yair Lotan, Douglas Scherr, Martin Haydter, Peter Nyirady, Jeremy Y C Teoh, Shin Egawa, Eva Compérat, Shahrokh F Shariat,
<h4>Background</h4>Elevated preoperative plasma levels of the angiogenesis-related marker VEGF have been associated with worse oncological outcomes in various malignancies.<h4>Objective</h4>To investigate the predictive/prognostic role of VEGF in patients with urothelial carcinoma of the bladder (UCB) treated with radical cystectomy (RC).<h4>Design, setting, and participants</h4>VEGF plasma levels were measured preoperatively in 1036 patients ... Read more >>
Eur Urol Focus (European urology focus)
[2021, :]
Cited: 0 times
Elio Mazzone, Giorgio Gandaglia, Guillame Ploussard, Giancarlo Marra, Massimo Valerio, Riccardo Campi, Andrea Mari, Andrea Minervini, Sergio Serni, Marco Moschini, Alessandro Marquis, Jean Baptiste Beauval, Roderick van den Bergh, Razvan-George Rahota, Timo Soeterik, Mathieu Roumiguiè, Luca Afferi, Junlong Zhuang, Hongqian Tuo, Agostino Mattei, Paolo Gontero, Vito Cucchiara, Armando Stabile, Nicola Fossati, Francesco Montorsi, Alberto Briganti,
<h4>Background</h4>Despite the key importance of magnetic resonance imaging (MRI) parameters, risk classification systems for biochemical recurrence (BCR) in prostate cancer (PCa) patients treated with radical prostatectomy (RP) are still based on clinical variables alone.<h4>Objective</h4>We aimed at developing and validating a novel classification integrating clinical and radiological parameters.<h4>Design, setting, and participants</h4>A ... Read more >>
Eur Urol (European urology)
[2021, :]
Cited: 0 times
Łukasz Nowak, Wojciech Krajewski, Joanna Chorbińska, Paweł Kiełb, Michał Sut, Marco Moschini, Jeremy Yuen-Chun Teoh, Keiichiro Mori, Francesco Del Giudice, Ekaterina Laukhtina, Chiara Lonati, Krzysztof Kaliszewski, Bartosz Małkiewicz, Tomasz Szydełko,
<h4>Background: </h4> The incidence of intravesical recurrence (IVR) following radical nephroureterectomy (RNU) is reported in up to 50% of patients with upper tract urothelial carcinoma (UTUC). It was suggested that preoperative diagnostic ureteroscopy (URS) could increase the IVR rate after RNU, however, the available data are often conflicting. Thus, in ... Read more >>
Cited: 0 times
Chiara Lonati, Francesco Esperto, Roberto M Scarpa, Rocco Papalia, Juan Gómez Rivas, Mario Alvarez-Maestro, Luca Afferi, Christian D Fankhauser, Agostino Mattei, Renzo Colombo, Francesco Montorsi, Alberto Briganti, Wojciech Krajewski, Roberto Carando, Ekaterina Laukhtina, Jeremy Y Teoh, Stefania Zamboni, Claudio Simeone, Marco Moschini, , ,
<h4>Introduction</h4>Despite bladder perforation (BP) is a frequent complication during transurethral resection of bladder (TURB) for bladder cancer (BCa), literature lacks systematic reviews focusing on this issue. We aimed to investigate incidence, diagnosis, therapy, and prognosis after BP during TURB for BCa; therapy was distinguished between conservative (without the need for ... Read more >>
Minerva Urol Nephrol (Minerva urology and nephrology)
[2021, :]
Cited: 0 times
Ekaterina Laukhtina, Keiichiro Mori, David D Andrea, Marco Moschini, Mohammad Abufaraj, Francesco Soria, Andrea Mari, Wojciech Krajewski, Simone Albisinni, Jeremy Yuen-Chun Teoh, Fahad Quhal, Reza Sari Motlagh, Hadi Mostafaei, Satoshi Katayama, Nico С Grossmann, Pawel Rajwa, Dmitry Enikeev, Kristin Zimmermann, Harun Fajkovic, Petr Glybochko, Shahrokh F Shariat, Benjamin Pradere, ,
We aimed to conduct a systematic review and meta-analysis assessing the incidence and risk factors of urethral recurrence (UR) as well as summarizing data on survival outcomes in patients with UR after radical cystectomy (RC) for bladder cancer. The MEDLINE and EMBASE databases were searched in February 2021 for studies ... Read more >>
Urol Oncol (Urologic oncology)
[2021, :]
Cited: 0 times
Satoshi Katayama, Keiichiro Mori, Benjamin Pradere, Hadi Mostafaei, Victor M Schuettfort, Fahad Quhal, Reza Sari Motlagh, Ekaterina Laukhtina, Marco Moschini, Nico C Grossmann, Yasutomo Nasu, Shahrokh F Shariat, Harun Fajkovic,
This systematic review and meta-analysis aimed to assess and compare the perioperative and oncological outcomes of intracorporeal (ICUD) and extracorporeal (ECUD) urinary diversion following robot-assisted radical cystectomy (RARC). A systematic literature search of articles was performed in PubMed<sup>®</sup>, Web of Science<sup>®</sup>, and Scopus<sup>®</sup> databases according to the Preferred Reporting Items ... Read more >>
Int J Clin Oncol (International journal of clinical oncology)
[2021, 26(9):1587-1599]
Cited: 0 times
Daniele Raggi, Marco Moschini, Andrea Necchi,
Cisplatin-based chemotherapy followed by radical cystectomy with bilateral pelvic lymph-node dissection is the current standard for cT2-4a N0 M0 urothelial bladder cancer. Immune checkpoint inhibitors have recently been tested in the neoadjuvant setting with promising pathological and survival results and a better safety profile. Excellent pathological responses have been observed, ... Read more >>
Eur Urol Open Sci (European urology open science)
[2021, 30:34-36]
Cited: 0 times
Victor M Schuettfort, Kilian Gust, David D'Andrea, Fahad Quhal, Hadi Mostafaei, Ekaterina Laukhtina, Keiichiro Mori, Michael Rink, Mohammad Abufaraj, Pierre I Karakiewicz, Stefano Luzzago, Morgan Rouprêt, Dmitry Enikeev, Kristin Zimmermann, Marina Deuker, Marco Moschini, Reza Sari Motlagh, Nico C Grossmann, Satoshi Katayama, Benjamin Pradere, Shahrokh F Shariat,
<h4>Background</h4>To investigate the predictive and prognostic value of the preoperative modified Glasgow Prognostic Score (mGPS) in patients with urothelial carcinoma of the bladder (UCB) treated with radical cystectomy (RC).<h4>Methods</h4>We conducted a retrospective analysis of an established multicenter database consisting of 4,335 patients who were treated with RC +/- adjuvant chemotherapy ... Read more >>
Minerva Urol Nephrol (Minerva urology and nephrology)
[2021, :]
Cited: 0 times
Armando Stabile, Rafael Sanchez-Salas, Rafael Tourinho-Barbosa, Petr Macek, Francesco Pellegrino, Giorgio Gandaglia, Marco Moschini, Nathalie Cathala, Annick Mombet, Francesco Montorsi, Alberto Briganti, Xavier Cathelineau,
J Urol (The Journal of urology)
[2021, 206(3):645]
Cited: 0 times
Marina Pizzighella, Franck Bruyere, Benoit Peyronnet, Vivien Grafeille, Nicolas Brichart, Keiichiro Mori, Gregory Verhoest, Karim Bensalah, Marco Moschini, Evenguelos Xylinas, Benjamin Pradere,
<h4>Purpose</h4>The bladder cuff management and its surgical approach represent an essential and debated step in radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). The objective of our study was to determine which bladder-cuff management has the best oncological outcomes in terms of bladder recurrence-free survival ( BRFS).<h4>Methods</h4>We retrospectively analyzed ... Read more >>
J Endourol (Journal of endourology)
[2021, :]
Cited: 0 times
Ekaterina Laukhtina, Pawel Rajwa, Keiichiro Mori, Marco Moschini, David D'Andrea, Mohammad Abufaraj, Francesco Soria, Andrea Mari, Wojciech Krajewski, Simone Albisinni, Jeremy Yuen-Chun Teoh, Fahad Quhal, Reza Sari Motlagh, Hadi Mostafaei, Satoshi Katayama, Nico C Grossmann, Dmitry Enikeev, Kristin Zimmermann, Harun Fajkovic, Petr Glybochko, Shahrokh F Shariat, Benjamin Pradere, ,
<h4>Context</h4>The question of the ability of frozen section analysis (FSA) to accurately detect malignant pathology intraoperatively has been discussed for many decades.<h4>Objective</h4>We aimed to conduct a systematic review and meta-analysis assessing the diagnostic estimates of FSA of the urethral and ureteral margins in patients treated with radical cystectomy (RC) for ... Read more >>
Eur Urol Focus (European urology focus)
[2021, :]
Cited: 1 time
Satoshi Katayama, Keiichiro Mori, Benjamin Pradere, Ekaterina Laukhtina, Victor M Schuettfort, Fahad Quhal, Reza Sari Motlagh, Hadi Mostafaei, Nico C Grossmann, Pawel Rajwa, Marco Moschini, Romain Mathieu, Mohammad Abufaraj, David D'Andrea, Eva Compérat, Martin Haydter, Shin Egawa, Yasutomo Nasu, Shahrokh F Shariat, ,
<h4>Purpose</h4>We assessed the prognostic value of systemic immune-inflammation index (SII) to refine risk stratification of the heterogeneous spectrum of patients with non-muscle-invasive bladder cancer (NMIBC) METHODS: In this multi-institutional cohort, preoperative blood-based SII was retrospectively assessed in 1117 patients with NMIBC who underwent transurethral resection of bladder (TURB) between 1996 ... Read more >>
World J Urol (World journal of urology)
[2021, :]
Cited: 1 time
Francesco Montorsi, Giorgio Gandaglia, Federico Dehò, Andrea Gallina, Marco Moschini, Andrea Salonia, Alberto Briganti,
Eur Urol Focus (European urology focus)
[2021, :]
Cited: 0 times
Ekaterina Laukhtina, Keiichiro Mori, Hadi Mostafaei, Axel S Merseburger, Peter Nyirady, Marco Moschini, Fahad Quhal, Victor M Schuettfort, Benjamin Pradere, Reza Sari Motlagh, Dmitry Enikeev, Shahrokh F Shariat, European Association Of Urology-Young Academic Urologists Eau-Yau Urothelial Carcinoma Working Group,
<b>Aim:</b> We aimed to compare the mortality rates related to adverse events (AEs) and discontinuation of treatment due to toxicity as well as all AEs of currently used regimens of second-line treatment strategies for advanced or metastatic urothelial carcinoma of the bladder. <b>Methods:</b> The MEDLINE and EMBASE databases were searched ... Read more >>
Immunotherapy (Immunotherapy)
[2021, 13(11):917-929]
Cited: 0 times
Simone Albisinni, Marco Moschini, Ettore Di Trapani, Francesco Soria, Andrea Mari, Atiqullah Aziz, Jeremy Teoh, Ekaterina Laukhtina, Keiichiro Mori, David D'Andrea, Diego M Carrion, Wojciech Krajewski, Mohammad Abufaraj, Alessia Cimadamore, Wei Shen Tan, Ronan Flippot, Jonathan Khalifa, Kimberly Gonsette, Benjamin Pradere, ,
<h4>Purpose</h4>There is no consensus on which items of Enhanced Recovery After Surgery (ERAS) should and should not be implemented in radical cystectomy (RC). The aim of this study is to report current practices across European high-volume RC centers involved in ERAS.<h4>Methods</h4>Based on the recommendations of the ERAS society, we developed ... Read more >>
World J Urol (World journal of urology)
[2021, :]
Cited: 0 times
Mario Pones, David D'Andrea, Keiichiro Mori, Mohammad Abufraj, Marco Moschini, Eva Comperat, Shahrokh F Shariat,
To evaluate oncological outcomes of primary versus secondary muscle-invasive bladder cancer treated with radical cystectomy. Medline, Embase, Scopus and Cochrane Library were searched for eligible studies. Hazard ratios for overall survival (OS), cancer specific survival (CSS) and progression free survival (PFS) were calculated using survival data extracted from Kaplan-Meier curves. ... Read more >>
Cancers (Basel) (Cancers)
[2021, 13(10):]
Cited: 0 times
Satoshi Katayama, Keiichiro Mori, Victor M Schuettfort, Benjamin Pradere, Hadi Mostafaei, Fahad Quhal, Pawel Rajwa, Reza Sari Motlagh, Ekaterina Laukhtina, Marco Moschini, Nico C Grossmann, Motoo Araki, Jeremy Yuen-Chun Teoh, Morgan Rouprêt, Vitaly Margulis, Dmitry Enikeev, Pierre I Karakiewicz, Mohammad Abufaraj, Eva Compérat, Yasutomo Nasu, Shahrokh F Shariat,
<h4>Background</h4>Among various clinicopathologic factors used to identify low-risk upper tract urothelial carcinoma (UTUC), tumor grade and stage are of utmost importance. The clinical value added by inclusion of other risk factors remains unproven.<h4>Objective</h4>To assess the performance of a tumor grade- and stage-based (GS) model to identify patients with UTUC for ... Read more >>
Eur Urol Focus (European urology focus)
[2021, :]
Cited: 0 times
Beat Foerster, Mohammad Abufaraj, Surena F Matin, Mounsif Azizi, Mohit Gupta, Wei-Ming Li, Thomas Seisen, Timothy Clinton, Evanguelos Xylinas, M Carmen Mir, Donald Schweitzer, Andrea Mari, Shoji Kimura, Marco Bandini, Romain Mathieu, Ja H Ku, Gautier Marcq, Georgi Guruli, Markus Grabbert, Anna K Czech, Tim Muilwijk, Armin Pycha, David D'Andrea, Firas G Petros, Philippe E Spiess, Trinity Bivalacqua, Wen-Jeng Wu, Morgan Rouprêt, Laura-Maria Krabbe, Kees Hendricksen, Shin Egawa, Alberto Briganti, Marco Moschini, Vivien Graffeille, Wassim Kassouf, Riccardo Autorino, Axel Heidenreich, Piotr Chlosta, Steven Joniau, Francesco Soria, Phillip M Pierorazio, Shahrokh F Shariat,
<h4>Background</h4>Several groups have proposed features to identify low-risk patients who may benefit from endoscopic kidney-sparing surgery in upper tract urothelial carcinoma (UTUC).<h4>Objective</h4>To evaluate standard risk stratification features, develop an optimal model to identify ≥pT2/N+ stage at radical nephroureterectomy (RNU), and compare it with the existing unvalidated models.<h4>Design, setting, and participants</h4>This ... Read more >>
Eur Urol (European urology)
[2021, 80(4):507-515]
Cited: 0 times
Alberto Martini, Luca Afferi, Stefania Zamboni, Julianne G Schultz, Chiara Lonati, Agostino Mattei, R Jeffrey Karnes, Matteo Soligo, Armando Stabile, Ettore Di Trapani, Ottavio De Cobelli, Giuseppe Simone, Claudio Simeone, Mario Alvarez-Maestro, Giorgio Gandaglia, Andrea Gallina, Renzo Colombo, Alberto Briganti, Francesco Montorsi, Evanguelos Xylinas, Shahrokh F Shariat, Marco Moschini,
<h4>Purpose</h4>Presently, major guidelines do not provide specific recommendations on oncologic surveillance for patients who harbor variant histology (VH) bladder cancer (BCa) at radical cystectomy. We aimed to create a personalized followup scheme that dynamically weighs other cause mortality (OCM) vs the risk of recurrence for VH BCa, and to compare ... Read more >>
J Urol (The Journal of urology)
[2021, 206(4):885-893]
Cited: 0 times
Chiara Lonati, Claudio Simeone, Marco Moschini,
J Urol (The Journal of urology)
[2021, 206(2):268]
Cited: 0 times
Keiichiro Mori, Benjamin Pradere, Marco Moschini, Hadi Mostafaei, Ekaterina Laukhtina, Victor M Schuettfort, Reza Sari Motlagh, Francesco Soria, Jeremy Y C Teoh, Shin Egawa, Thomas Powles, Shahrokh F Shariat, ,
<h4>Introduction</h4>Platinum-based combination chemotherapy is the standard treatment for patients with chemotherapy-eligible metastatic urothelial carcinoma (mUC). Immune-checkpoint inhibitors (ICIs) are currently assessed in this setting. This review aimed to assess the role of ICIs alone or in combination as first-line treatment in chemotherapy-eligible patients with mUC.<h4>Methods</h4>Multiple databases were searched for articles ... Read more >>
Eur J Cancer (European journal of cancer (Oxford, England : 1990))
[2021, 151:35-48]
Cited: 0 times
Victor M Schuettfort, Benjamin Pradere, Quoc-Dien Trinh, David D'Andrea, Fahad Quhal, Hadi Mostafaei, Ekaterina Laukhtina, Keiichiro Mori, Reza Sari Motlagh, Michael Rink, Pierre I Karakiewicz, Piotr Chlosta, Jeremy Yuen-Chun Teoh, Yair Lotan, Douglas Scherr, Mohammad Abufaraj, Marco Moschini, Shahrokh F Shariat,
<h4>Background</h4>Preoperative plasma levels of Interleukin 6 (IL6) and its soluble receptor (IL6sR) have previously been associated with oncologic outcomes in urothelial carcinoma of the bladder (UCB); however, external validation in patients treated with radical cystectomy (RC) for UCB is missing.<h4>Patients/methods</h4>We prospectively collected preoperative plasma from 1,036 consecutive patients at two ... Read more >>
Cancer Immunol Immunother (Cancer immunology, immunotherapy : CII)
[2021, :]
Cited: 0 times